206 related articles for article (PubMed ID: 21626875)
1. [Clinical validity of renal function markers including serum cystatin C on chronic kidney disease classification].
Suzuki Y; Matsushita K; Yoshida T; Sawabe Y; Nomura F
Rinsho Byori; 2011 Apr; 59(4):345-51. PubMed ID: 21626875
[TBL] [Abstract][Full Text] [Related]
2. [Usefulness of serum cystatin C for the diagnosis of impaired renal function].
Oyabu C; Hayashi N; Sugiyama D; Umezu M; Mukai M; Kawano S; Kumagai S
Rinsho Byori; 2006 Dec; 54(12):1204-8. PubMed ID: 17265892
[TBL] [Abstract][Full Text] [Related]
3. Cystatin C and beta2-microglobulin: markers of glomerular filtration in critically ill children.
Herrero-Morín JD; Málaga S; Fernández N; Rey C; Diéguez MA; Solís G; Concha A; Medina A
Crit Care; 2007; 11(3):R59. PubMed ID: 17519026
[TBL] [Abstract][Full Text] [Related]
4. [Comparison between serum cystatin C and estimation of GFR by the MDRD study equation for chronic kidney disease].
Sakaguchi S; Tanaka A; Kawanishi T; Tanaka A; Koshikawa M; Kuwahara T
Nihon Jinzo Gakkai Shi; 2008; 50(8):1011-6. PubMed ID: 19172802
[TBL] [Abstract][Full Text] [Related]
5. [Prospective evaluation of renal function by serum cystatin-C: comparison with three other parameters of glomerular filtration rate].
Tamba K; Kusano E; Ando Y; Asano Y
Nihon Jinzo Gakkai Shi; 2001 Nov; 43(8):646-50. PubMed ID: 11808075
[TBL] [Abstract][Full Text] [Related]
6. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.
Oddoze C; Morange S; Portugal H; Berland Y; Dussol B
Am J Kidney Dis; 2001 Aug; 38(2):310-6. PubMed ID: 11479157
[TBL] [Abstract][Full Text] [Related]
7. [Usefulness of serum cystatin-C as a marker of the renal function: a comparative evaluation with beta 2-microglobulin, alpha 1-microglobulin and creatinine].
Hotta O; Yusa N; Mukaiyama I; Taguma Y
Nihon Jinzo Gakkai Shi; 1999 Dec; 41(8):797-803. PubMed ID: 10655728
[TBL] [Abstract][Full Text] [Related]
8. [Usefulness of the formula for predicting creatinine clearance from serum cystatin C].
Oyabu C; Hayashi N; Sugiyama D; Umezu M; Kinoshita S; Hayashi H; Kawano S; Kumagai S
Rinsho Byori; 2008 Dec; 56(12):1093-9. PubMed ID: 19175073
[TBL] [Abstract][Full Text] [Related]
9. Cystatin C is a sensitive marker for detecting a reduced glomerular filtration rate when assessing chronic kidney disease in patients with rheumatoid arthritis and secondary amyloidosis.
Sato H; Kuroda T; Tanabe N; Ajiro J; Wada Y; Murakami S; Sakatsume M; Nakano M; Gejyo F
Scand J Rheumatol; 2010; 39(1):33-7. PubMed ID: 20132068
[TBL] [Abstract][Full Text] [Related]
10. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function.
Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
Nephrol Dial Transplant; 2006 Jul; 21(7):1855-62. PubMed ID: 16524933
[TBL] [Abstract][Full Text] [Related]
11. Can cystatin C be a better marker for the early detection of renal damage in primary hypertensive patients?
Ozer BA; Dursun B; Baykal A; Gultekin M; Suleymanlar G
Ren Fail; 2005; 27(3):247-53. PubMed ID: 15957539
[TBL] [Abstract][Full Text] [Related]
12. Assessment of glomerular filtration rate by serum cystatin C in patients undergoing coronary artery bypass grafting.
Wang QP; Gu JW; Zhan XH; Li H; Luo XH
Ann Clin Biochem; 2009 Nov; 46(Pt 6):495-500. PubMed ID: 19729502
[TBL] [Abstract][Full Text] [Related]
13. Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients.
Villa P; Jiménez M; Soriano MC; Manzanares J; Casasnovas P
Crit Care; 2005 Apr; 9(2):R139-43. PubMed ID: 15774046
[TBL] [Abstract][Full Text] [Related]
14. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.
Malyszko J; Bachorzewska-Gajewska H; Sitniewska E; Malyszko JS; Poniatowski B; Dobrzycki S
Ren Fail; 2008; 30(6):625-8. PubMed ID: 18661413
[TBL] [Abstract][Full Text] [Related]
15. Serum cystatin C as an endogenous marker of renal function in patients with chronic kidney disease.
Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
Ren Fail; 2008; 30(2):181-6. PubMed ID: 18300118
[TBL] [Abstract][Full Text] [Related]
16. Measurement of renal function in kidney donors using serum cystatin C and beta(2)-microglobulin.
John GT; Fleming JJ; Talaulikar GS; Selvakumar R; Thomas PP; Jacob CK
Ann Clin Biochem; 2003 Nov; 40(Pt 6):656-8. PubMed ID: 14629804
[TBL] [Abstract][Full Text] [Related]
17. Predictive power of serum cystatin C to detect acute kidney injury and pediatric-modified RIFLE class in children undergoing cardiac surgery.
Hassinger AB; Backer CL; Lane JC; Haymond S; Wang D; Wald EL
Pediatr Crit Care Med; 2012 Jul; 13(4):435-40. PubMed ID: 22596066
[TBL] [Abstract][Full Text] [Related]
18. Cystatin C or creatinine for detection of stage 3 chronic kidney disease in anorexia nervosa.
Delanaye P; Cavalier E; Radermecker RP; Paquot N; Depas G; Chapelle JP; Scheen AJ; Krzesinski JM
Nephron Clin Pract; 2008; 110(3):c158-63. PubMed ID: 18953178
[TBL] [Abstract][Full Text] [Related]
19. Serum cystatin C in elderly cardiac surgery patients.
Ristikankare A; Pöyhiä R; Kuitunen A; Skrifvars M; Hämmäinen P; Salmenperä M; Suojaranta-Ylinen R
Ann Thorac Surg; 2010 Mar; 89(3):689-94. PubMed ID: 20172110
[TBL] [Abstract][Full Text] [Related]
20. Discrepancies between creatinine-based and cystatin C-based equations in estimating prevalence of stage 3 chronic kidney disease in an elderly population.
Delanaye P; Cavalier E; Saint-Remy A; Lutteri L; Krzesinski JM
Scand J Clin Lab Invest; 2009; 69(3):344-9. PubMed ID: 19051098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
